Valera Pharmaceutical (VLRX)
Valera Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, acquisition, and commercialization of products for the treatment of urological and endocrine conditions, diseases, and disorders in the United States. The company develops various hydrogel-based implants, which are designed to release therapeutic agents at a controlled rate for up to 12 months. It provides Vantas, a 12-month implant for the palliative treatment of advanced prostate cancer that delivers histrelin, a luteinizing hormone-releasing hormone agonist. Valera Pharmaceuticals also developed Supprelin-LA, a 12-month implant to deliver histrelin for the treatment of central precocious puberty. Its...
read more
QUOTE
As of 02:34PM EDT May 25, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
VALERA PHARMACEUTICAL (VLRX) MESSAGE BOARD
| Post # |
Subject |
Re |
Name |
Date |
| There are no comments. |
someone replies to your post?